Sariya Wongsaengsak, MD in Charleston, SC - Medicare Student in an Organized Health Care Education/Training Program

Sariya Wongsaengsak, MD is a medicare enrolled "Student In An Organized Health Care Education/training Program" physician in Charleston, South Carolina. Her current practice location is 39 Sabin St Charleston Sc 29425 Msc 635, Charleston, South Carolina. You can reach out to her office (for appointments etc.) via phone at (843) 792-1298.

Sariya Wongsaengsak is licensed to practice in Texas (license number 679355) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1265927966.

Contact Information

	Sariya Wongsaengsak, MD
	39 Sabin St Charleston Sc 29425 Msc 635, Charleston, SC 29425-0001
	(843) 792-1298
	Not Available

Physician's Profile

Full Name	Sariya Wongsaengsak
Gender	Female
Speciality	Student In An Organized Health Care Education/training Program
Location	39 Sabin St Charleston Sc 29425 Msc 635, Charleston, South Carolina
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1265927966
Provider Enumeration Date: 06/25/2018
Last Update Date: 02/25/2024

Medicare PECOS Information:

PECOS PAC ID: 6507262144
Enrollment ID: I20210908001267

Medical Identifiers

Medical identifiers for Sariya Wongsaengsak such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1265927966	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RH0003X	Internal Medicine - Hematology & Oncology	85478 (South Carolina)	Secondary
390200000X	Student In An Organized Health Care Education/training Program	679355 (Texas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sariya Wongsaengsak is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Sariya Wongsaengsak, MD 3601 4th St Internal Medicine Department, Lubbock, TX 79430-0001 Ph: (806) 743-6840	Sariya Wongsaengsak, MD 39 Sabin St Charleston Sc 29425 Msc 635, Charleston, SC 29425-0001 Ph: (843) 792-1298

News Archive

Twitter: A popular source for receiving and sharing new information about vaccines

Twitter is a popular source for receiving and sharing new information about vaccines, and also a basically reliable one, according to a study published in the June issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).

Ludwig scientists develop and test individualized ovarian cancer vaccine

A Ludwig Cancer Research study has shown that an entirely new type of personalized cancer vaccine induces novel, potent and clinically effective immune responses in patients receiving a combination of standard therapies for recurrent, stage III and IV ovarian cancer.

Semafore's SF1126 peptidic prodrug demonstrates clinical activity in chronic lymphocytic leukemia

Semafore Pharmaceuticals today announced the presentation of preliminary clinical data demonstrating that SF1126 has clinical activity in chronic lymphocytic leukemia (CLL). SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). The results were presented at Cambridge Healthtech Institute's 8th Annual Next-Gen Kinase Inhibitors Oncology & Beyond Conference being held June 21-23, 2010, in Cambridge, Massachusetts.

Researchers to study integration of diabetes, hypertension screening into HIV screening

The success of HIV treatment programs depends upon the identification, enrollment, and retention of HIV-infected individuals, but public health officials have learned that there are numerous barriers to such success at every point in this care continuum.

Sariya Wongsaengsak, MD - Medicare Student in an Organized Health Care Education/Training Program in Charleston, SC